Everything you need to win Otsuka Precision Health (OPH) and Amalgam Rx — in one platform.
Who to reach, what to say, and why now on Otsuka Precision Health (OPH) and Amalgam Rx — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.
Get the full Deep Dive on Otsuka Precision Health (OPH) and Amalgam Rx — free.
One free Deep Dive, emailed to you. No spam; unsubscribe anytime.
The decision-maker’s email and mobile — dial in-browser.
Otsuka Precision Health, Inc. (OPH) and Amalgam Rx Announce Launch of Elevmi™ for Caregivers Supporting Patients with Alzheimer’s Disease
Oct 07, 2024•over 1 year ago
Contract Type
partnership
WilmingtonHealth Care
Description
Otsuka Precision Health, Inc. (OPH) and Amalgam Rx, Inc. have partnered to launch Elevmi™ – an intelligent digital application that helps caregivers support loved ones with Alzheimer’s Disease. Elevmi™ aims to reduce the stress and burden experienced by caregivers by enhancing their ability to manage and coordinate care for Alzheimer’s patients.
Company Information
Company
Otsuka Precision Health (OPH) and Amalgam Rx
Location
Wilmington, Delaware, United States
About
Otsuka Precision Health, Inc. (OPH) and Amalgam Rx, Inc. have partnered to launch Elevmi™ – an intelligent digital application that helps caregivers support loved ones with Alzheimer’s Disease.
Predictive Intelligence
Strategic
ML-powered predictions for Otsuka Precision Health (OPH) and Amalgam Rx's next move